| Jeremy Anuntiyo Md Inc | |
|
1360 W 6th St Ste 310 San Pedro CA 90732-3599 | |
| (562) 529-7772 | |
| (562) 529-5449 |
| Full Name | Jeremy Anuntiyo Md Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 1360 W 6th St Ste 310, San Pedro, California |
| Authorized Official Name and Position | Jeremy Anuntiyo (CHIEF EXECUTIVE OFFICER) |
| Authorized Official Contact | 5625297772 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Jeremy Anuntiyo Md Inc 1360 W 6th St Ste 310 San Pedro CA 90732-3599 Ph: (562) 529-7772 | Jeremy Anuntiyo Md Inc 1360 W 6th St Ste 310 San Pedro CA 90732-3599 Ph: (562) 529-7772 |
| NPI Number | 1013168749 |
|---|---|
| Provider Enumeration Date | 09/30/2008 |
| Last Update Date | 02/14/2020 |
| Medicare PECOS PAC ID | 8426111642 |
|---|---|
| Medicare Enrollment ID | O20090114000763 |
News Archive
By combining conventional medical imaging with some of the same 3-D modeling techniques used in Hollywood blockbusters, researchers are offering new hope to victims of serious facial injuries. Results of a new study on human face transplantation, led by Darren M. Smith, M.D., plastic surgery resident at the University of Pittsburgh Medical Center (UPMC), were presented today at the annual meeting of the Radiological Society of North America (RSNA).
Covidien, a leading global provider of healthcare products, today announced the latest additions to its growing bariatric surgery portfolio of products and services designed to improve patient and surgeon experiences with weight loss surgery and other procedures.
A team of researchers in the United States have conducted an extensive literature review looking at the usage of convalescent plasma from recovered COVID-19 patients to treat those with an impaired immune system. Their study, titled "Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency: A systematic review," has been released on medRxiv*, the preprint server.
Recognizing that treatment of chronic pain can be confounding, the Neuromodulation Appropriateness Consensus Committee, an international group of more than 60 leading pain specialists, has created the first consensus guidelines for the use of neurostimulation in chronic pain.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013168749 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | (* (Not Available)) | Primary |
| Provider Name | Jeremy Anuntiyo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1811183585 PECOS PAC ID: 4082635776 Enrollment ID: I20080609000401 |
News Archive
By combining conventional medical imaging with some of the same 3-D modeling techniques used in Hollywood blockbusters, researchers are offering new hope to victims of serious facial injuries. Results of a new study on human face transplantation, led by Darren M. Smith, M.D., plastic surgery resident at the University of Pittsburgh Medical Center (UPMC), were presented today at the annual meeting of the Radiological Society of North America (RSNA).
Covidien, a leading global provider of healthcare products, today announced the latest additions to its growing bariatric surgery portfolio of products and services designed to improve patient and surgeon experiences with weight loss surgery and other procedures.
A team of researchers in the United States have conducted an extensive literature review looking at the usage of convalescent plasma from recovered COVID-19 patients to treat those with an impaired immune system. Their study, titled "Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency: A systematic review," has been released on medRxiv*, the preprint server.
Recognizing that treatment of chronic pain can be confounding, the Neuromodulation Appropriateness Consensus Committee, an international group of more than 60 leading pain specialists, has created the first consensus guidelines for the use of neurostimulation in chronic pain.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
› Verified 9 days ago
News Archive
By combining conventional medical imaging with some of the same 3-D modeling techniques used in Hollywood blockbusters, researchers are offering new hope to victims of serious facial injuries. Results of a new study on human face transplantation, led by Darren M. Smith, M.D., plastic surgery resident at the University of Pittsburgh Medical Center (UPMC), were presented today at the annual meeting of the Radiological Society of North America (RSNA).
Covidien, a leading global provider of healthcare products, today announced the latest additions to its growing bariatric surgery portfolio of products and services designed to improve patient and surgeon experiences with weight loss surgery and other procedures.
A team of researchers in the United States have conducted an extensive literature review looking at the usage of convalescent plasma from recovered COVID-19 patients to treat those with an impaired immune system. Their study, titled "Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency: A systematic review," has been released on medRxiv*, the preprint server.
Recognizing that treatment of chronic pain can be confounding, the Neuromodulation Appropriateness Consensus Committee, an international group of more than 60 leading pain specialists, has created the first consensus guidelines for the use of neurostimulation in chronic pain.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
› Verified 9 days ago
Ramin Alizadeh Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1534 W 25th St, San Pedro, CA 90732 Phone: 310-547-3034 Fax: 310-548-5242 | |
San Miguel Urgent Care San Pedro Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 525 W 7th St, San Pedro, CA 90731 Phone: 424-264-5630 | |
Mark Perez Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1350 W 6th St, 2nd Floor #7, San Pedro, CA 90732 Phone: 310-832-1126 Fax: 310-831-3000 | |
Multicare Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 505 S Pacific Ave, Suite #201, San Pedro, CA 90731 Phone: 424-570-6960 Fax: 424-570-6952 | |
Dr Mona Shah Professional Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1600 S Gaffey St, San Pedro, CA 90731 Phone: 310-548-0201 Fax: 310-547-3340 | |
Total Body Advanced Medicine, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 789 W 9th St, San Pedro, CA 90731 Phone: 310-519-1557 Fax: 310-519-0330 |